Press Release: ACELYRIN, INC. Reports Third Quarter 2024 Financial Results and Recent Highlights

Dow Jones11-14 05:00
Loss from operations      (54,747)      (94,423)     (230,546)     (316,952) 
 
 Change in fair 
  value of 
  derivative tranche 
  liability                     -             -             -        10,291 
 Interest income            7,535        10,502        25,132        20,486 
 Other income 
  (expense), net           (1,336)          (19)       36,221          (254) 
Net loss              $   (48,548)  $   (83,940)  $  (169,193)  $  (286,429) 
                       ----------    ----------    ----------    ---------- 
Other comprehensive 
gain (loss) 
 Unrealized gain 
  (loss) on 
  short-term 
  marketable 
  securities, net             551           (94)          222            36 
  Total other 
   comprehensive 
   gain (loss)        $       551   $       (94)  $       222   $        36 
                       ----------    ----------    ----------    ---------- 
Net loss and other 
 comprehensive loss   $   (47,997)  $   (84,034)  $  (168,971)  $  (286,393) 
                       ==========    ==========    ==========    ========== 
Net loss per share 
 attributable to 
 common 
 stockholders, basic 
 and diluted          $     (0.49)  $     (0.87)  $     (1.71)  $     (4.68) 
Weighted-average 
 common shares 
 outstanding, basic 
 and diluted           99,835,707    96,872,747    98,973,518    61,138,105 
                       ==========    ==========    ==========    ========== 
 
 
                             ACELYRIN, INC. 
                Selected Consolidated Balance Sheet Data 
                              (unaudited) 
                             (in thousands) 
 
                           September 30,              December 31, 
                      ------------------------  ------------------------ 
                                2024                      2023 
                          ----------------          ---------------- 
 Cash and cash 
  equivalents          $           216,326       $           218,097 
 Short-term 
  marketable 
  securities                       346,047                   503,229 
 Total assets                      618,310                   742,690 
 Total liabilities                  90,029                    86,353 
 Accumulated deficit              (657,912)                 (488,719)

ACELYRIN Contacts:

Tyler Marciniak

Vice President of Investor Relations and Corporate Affairs

investors@acelyrin.com

media@acelyrin.com

(END) Dow Jones Newswires

November 13, 2024 16:00 ET (21:00 GMT)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment